Cipla Ltd. (CIPL)

1,548.35 +3.50 (+0.23%)
Real-time Data INR Disclaimer

Cipla Ltd. Company Profile

Equity Type
Cipla Limited, together with its subsidiaries, manufactures, develops, and sells pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New ventures segments. It also offers active pharmaceutical ingredients; and formulations in various therapeutic areas, such as MI, angina, heart failure, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, HIV, respiratory, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women’s health, ophthalmology, and neuro psychiatry. In addition, the company provides respiratory products, including inhalers and nasal sprays, as well as other respiratory products consists of injectables and biosimilars. Further, it offers Easylax and Easylax L, a liquid paraffin for constipation. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.
Contact Information
Ganpatrao Kadam Marg Lower Parel Mumbai,400013 India
91 22 2482 6000
91 22 2482 6120
Top Executives
Mustafa Khwaja Hamied 81 1977 Non-Executive Vice-Chairman
Yusuf Khwaja Hamied 85 1972 Non-Executive Chairman
Umang Vohra 50 2015 MD, Global CEO & Executive Director
Adil Siraj Zainulbhai 69 2014 Lead Independent Non-Executive Director
S. Radhakrishnan 67 2010 Non-Executive Non-Independent Director
Samina Hamied 48 2015 Non-Executive Director
Mandar Purushottam Vaidya 48 2022 Independent Director
Balram Bhargava 0 2024 Additional & Independent Director
Punita Lal 62 2014 Independent Non-Executive Director
Robert A. Stewart 56 2021 Independent Director
Ashok U. Sinha 72 2013 Independent Non-Executive Director
Clear All
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles